Literature DB >> 17904038

Validity of a retrospective National Institutes of Health Stroke Scale scoring methodology in patients with severe stroke.

Christopher J Lindsell1, Kathleen Alwell, Charles J Moomaw, Dawn O Kleindorfer, Daniel Woo, Matthew L Flaherty, Ellen L Air, Alexander T Schneider, Irene Ewing, Joseph P Broderick, Joel Tsevat, Brett M Kissela.   

Abstract

OBJECTIVE: Quantifying stroke severity is essential for interpreting outcomes in stroke studies; severity impacts outcomes. Because outcome studies often enroll patients some time after stroke and there is little standardization of the history and physical examination, objective measurement of stroke severity is limited. A method for retrospectively scoring the National Institutes of Health Stroke Scale (NIHSS) based on history and physical examination has been proposed, but has yet to be validated in patients with higher NIHSS score. We evaluate the validity of this scoring method across the spectrum of the NIHSS scores.
METHODS: The retrospective scoring algorithm was applied to history and physical examinations documented for 58 patients with ischemic stroke presenting to any of 17 regional acute care facilities who had a NIHSS score recorded by a stroke team physician. The retrospective NIHSS score was obtained by standardized chart review. Linear regression was used to estimate scale-dependent and scale-independent bias. Limits of agreement quantify deviation of the retrospective NIHSS score from the prospective NIHSS score.
RESULTS: Mean (SD) age at stroke was 66 (14) years; 27 (46.6%) patients were men, and 38 (65.5%) were white. The mean (SD) prospective NIHSS score was 13.6 (7.8); the mean (SD) retrospective NIHSS score was 13.7 (7.8). There were 23 (40%) prospective NIHSS scores above 15, and 13 scores (22%) above 20. The linear regression constant was 0.290 (95% confidence interval -0.107, 0.687); the slope was 0.987 (95% confidence interval 0.962, 1.013). The R(2) for the model was 0.991. Limits of agreement were -1.35 and 1.59.
CONCLUSION: The retrospective NIHSS appears valid across the entire spectrum of scores.

Entities:  

Year:  2005        PMID: 17904038     DOI: 10.1016/j.jstrokecerebrovasdis.2005.08.004

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  15 in total

1.  Patients living in impoverished areas have more severe ischemic strokes.

Authors:  Dawn Kleindorfer; Christopher Lindsell; Kathleen A Alwell; Charles J Moomaw; Daniel Woo; Matthew L Flaherty; Pooja Khatri; Opeolu Adeoye; Simona Ferioli; Brett M Kissela
Journal:  Stroke       Date:  2012-07-05       Impact factor: 7.914

2.  Estimated Impact of Emergency Medical Service Triage of Stroke Patients on Comprehensive Stroke Centers: An Urban Population-Based Study.

Authors:  Brian S Katz; Opeolu Adeoye; Heidi Sucharew; Joseph P Broderick; Jason McMullan; Pooja Khatri; Michael Widener; Kathleen S Alwell; Charles J Moomaw; Brett M Kissela; Matthew L Flaherty; Daniel Woo; Simona Ferioli; Jason Mackey; Sharyl Martini; Felipe De Los Rios la Rosa; Dawn O Kleindorfer
Journal:  Stroke       Date:  2017-07-12       Impact factor: 7.914

3.  How often are patients with ischemic stroke eligible for decompressive hemicraniectomy?

Authors:  Ralph Rahme; Richard Curry; Dawn Kleindorfer; Jane C Khoury; Andrew J Ringer; Brett M Kissela; Kathleen Alwell; Charles J Moomaw; Matthew L Flaherty; Pooja Khatri; Daniel Woo; Simona Ferioli; Joseph Broderick; Opeolu Adeoye
Journal:  Stroke       Date:  2011-10-27       Impact factor: 7.914

4.  Distribution of National Institutes of Health stroke scale in the Cincinnati/Northern Kentucky Stroke Study.

Authors:  Mathew Reeves; Jane Khoury; Kathleen Alwell; Charles Moomaw; Matthew Flaherty; Daniel Woo; Pooja Khatri; Opeolu Adeoye; Simona Ferioli; Brett Kissela; Dawn Kleindorfer
Journal:  Stroke       Date:  2013-09-03       Impact factor: 7.914

5.  Hyperlipidemia is associated with lower risk of poststroke mortality independent of statin use: A population-based study.

Authors:  Samrat Yeramaneni; Dawn O Kleindorfer; Heidi Sucharew; Kathleen Alwell; Charles J Moomaw; Matthew L Flaherty; Daniel Woo; Opeolu Adeoye; Simona Ferioli; Felipe de Los Rios La Rosa; Sharyl Martini; Jason Mackey; Pooja Khatri; Brett M Kissela; Jane C Khoury
Journal:  Int J Stroke       Date:  2016-09-24       Impact factor: 5.266

6.  Population-based study of wake-up strokes.

Authors:  J Mackey; D Kleindorfer; H Sucharew; C J Moomaw; B M Kissela; K Alwell; M L Flaherty; D Woo; P Khatri; O Adeoye; S Ferioli; J C Khoury; R Hornung; J P Broderick
Journal:  Neurology       Date:  2011-05-10       Impact factor: 9.910

7.  Predictors of percutaneous endoscopic gastrostomy tube placement in patients with severe dysphagia from an acute-subacute hemispheric infarction.

Authors:  Sandeep Kumar; Susan Langmore; Richard P Goddeau; Adel Alhazzani; Magdy Selim; Louis R Caplan; Lin Zhu; Adnan Safdar; Cynthia Wagner; Colleen Frayne; David E Searls; Gottfried Schlaug
Journal:  J Stroke Cerebrovasc Dis       Date:  2010-09-19       Impact factor: 2.136

8.  Profiles of the National Institutes of Health Stroke Scale items as a predictor of patient outcome.

Authors:  Heidi Sucharew; Jane Khoury; Charles J Moomaw; Kathleen Alwell; Brett M Kissela; Samir Belagaje; Opeolu Adeoye; Pooja Khatri; Daniel Woo; Matthew L Flaherty; Simona Ferioli; Laura Heitsch; Joseph P Broderick; Dawn Kleindorfer
Journal:  Stroke       Date:  2013-05-23       Impact factor: 7.914

9.  Clinical prediction of functional outcome after ischemic stroke: the surprising importance of periventricular white matter disease and race.

Authors:  Brett Kissela; Christopher J Lindsell; Dawn Kleindorfer; Kathleen Alwell; Charles J Moomaw; Daniel Woo; Matthew L Flaherty; Ellen Air; Joseph Broderick; Joel Tsevat
Journal:  Stroke       Date:  2008-12-24       Impact factor: 7.914

10.  Slim stroke scales for assessing patients with acute stroke: ease of use or loss of valuable assessment data?

Authors:  Brandon R Nye; Christina E Hyde; Georgios Tsivgoulis; Karen C Albright; Andrei V Alexandrov; Anne W Alexandrov
Journal:  Am J Crit Care       Date:  2012-11       Impact factor: 2.228

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.